ArticleScientific reports2026
A cognitive divide in active surveillance acceptance persists between surgeons and endocrinologists managing low-risk thyroid cancer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To quantify the specialty-specific perceptions and modifiable determinants behind AS recommendations-a critical barrier rooted in physician attitudes- this study surveyed eight high-volume hospitals in Jiangsu Province, each performing ≥ 2,500 thyroid surgeries annually. A total of 58 physicians from relevant departments meeting the following criteria were surveyed: Surgery: Perform over 100 thyroid cancer surgeries annually and diagnose at least 300 cases; Endocrinology/Ultrasound: Conduct at least 300 patient consultations per year; Pathology: Issue at least 300 thyroid cancer pathology reports annually; Nuclear Medicine: Perform radionuclide scans on at least 300 patients per year. The Kruskal-Wallis test and ordinal logistic regression were used to compare attitudes toward AS across specialties and examine their association with professional title hierarchy, respectively. A survey of 41 physicians across five specialties revealed high guideline familiarity (85.37%) yet low clinical adoption. While 53.66% would biopsy AS-eligible patients, 90.2% would recommend surgery within three months of papillary carcinoma confirmation. When patients suitable for AS experience anxiety, 75% of endocrinologists would advise surgery. Attending physicians were 4.2 times more likely to endorse AS than professors (P = 0.006). This disparity stems from specialty-specific cognitive frameworks, necessitating precision interventions like medicolegal support for surgeons and anxiety protocols for endocrinologists to bridge the gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.